Insider Selling: Anthem (NASDAQ:ANTX) Insider Sells $24,790.65 in Stock

Anthem, Inc. (NASDAQ:ANTX) insider Joshua Eizen sold 5,945 shares of the firm’s stock in a transaction on Wednesday, July 8th. The shares were sold at an average price of $4.17, for a total value of $24,790.65. Following the sale, the insider directly owned 206,554 shares in the company, valued at approximately $861,330.18. This trade represents a 2.80% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Anthem Trading Down 2.8%

ANTX traded down $0.13 on Friday, reaching $4.50. The stock had a trading volume of 591,722 shares, compared to its average volume of 820,806. Anthem, Inc. has a fifty-two week low of $1.00 and a fifty-two week high of $6.91. The firm has a 50-day moving average of $4.60 and a 200-day moving average of $3.10. The company has a market capitalization of $162.09 million, a price-to-earnings ratio of -4.09 and a beta of -0.99.

Anthem (NASDAQ:ANTX) last announced its quarterly earnings results on Monday, May 11th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.06).

Hedge Funds Weigh In On Anthem

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Spruce Street Capital LP acquired a new stake in shares of Anthem during the first quarter worth $5,576,000. OMERS ADMINISTRATION Corp acquired a new position in Anthem in the first quarter valued at $54,000. Commodore Capital LP bought a new stake in Anthem during the first quarter valued at $7,981,000. ADAR1 Capital Management LLC acquired a new stake in Anthem during the 1st quarter worth about $47,000. Finally, Ally Bridge Group NY LLC acquired a new stake in Anthem during the 1st quarter worth about $1,800,000. 90.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on ANTX shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Anthem in a research report on Monday. Leerink Partners raised shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price target for the company in a research note on Thursday, May 14th. Finally, Wall Street Zen upgraded shares of Anthem from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $9.00.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.